title: India's health ministry bans pioglitazone, metamizole, and flupentixol-melitracen.
authors.forename: Soumyadeep
authors.initials: S
authors.lastname: Bhaumik
mesh_terms: D000873:Anthracenes / Q000009:adverse effects*; D004177:Dipyrone / Q000009:adverse effects*; D004338:Drug Combinations; D004335:Drug and Narcotic Control; D005475:Flupenthixol / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007194:India; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D000873:Anthracenes; D004338:Drug Combinations; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; C000851:flupentixol, melitracen drug combination; D004177:Dipyrone; D005475:Flupenthixol; D000077205:Pioglitazone